Plain-English translation of NCT05516667 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This is a research study that brings together three groups of people: those diagnosed with Alzheimer's disease, the people who care for them, and their adult family members who may be at higher risk. The study will follow these family groups for two years, collecting health information through visits and questionnaires, to learn more about how Alzheimer's develops and how it affects both patients and caregivers.
Right now, doctors don't have a cure for Alzheimer's disease, but research suggests it might be preventable if we catch it early. This study aims to fill important gaps in our understanding—particularly by tracking simple blood tests, exploring newly recognized risk factors like hearing problems, and learning how the disease affects caregivers' health and wellbeing over time.
You likely qualify if…
You likely don't qualify if…
You would join as part of a family group—either as a patient, caregiver, or family member (or in some cases, filling multiple roles). Your group would visit a memory clinic at baseline, 12 months, and 24 months for medical check-ups and tests. Between visits, you would complete regular questionnaires about health either online, by mail, or during clinic visits. The entire study lasts two years.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
France